<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D20E1752-0560-4A6B-8694-91F9DCB1DD55"><gtr:id>D20E1752-0560-4A6B-8694-91F9DCB1DD55</gtr:id><gtr:name>Psychiatric GWAS Consortium (PGC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D20E1752-0560-4A6B-8694-91F9DCB1DD55"><gtr:id>D20E1752-0560-4A6B-8694-91F9DCB1DD55</gtr:id><gtr:name>Psychiatric GWAS Consortium (PGC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E3EF6E4D-FDE7-41B0-AFF5-627443C3267A"><gtr:id>E3EF6E4D-FDE7-41B0-AFF5-627443C3267A</gtr:id><gtr:firstName>Stephan</gtr:firstName><gtr:surname>Collishaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B1FE4EBC-AF3A-4AE4-A2ED-4BD58E1E2544"><gtr:id>B1FE4EBC-AF3A-4AE4-A2ED-4BD58E1E2544</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Conlon</gtr:otherNames><gtr:surname>O'Donovan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CB22C6B6-828E-4534-8951-01D697A5803D"><gtr:id>CB22C6B6-828E-4534-8951-01D697A5803D</gtr:id><gtr:firstName>Anita</gtr:firstName><gtr:surname>Thapar</gtr:surname><gtr:orcidId>0000-0002-3689-737X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/52C74994-17A3-472A-BF00-98F901C65D44"><gtr:id>52C74994-17A3-472A-BF00-98F901C65D44</gtr:id><gtr:firstName>Barbara</gtr:firstName><gtr:surname>Maughan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FM012964%2F1"><gtr:id>0EB05762-BD6E-4E3D-8760-516AEFB8D42D</gtr:id><gtr:title>Identifying the impact of mental disorder risk alleles on childhood neurodevelopment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M012964/1</gtr:grantReference><gtr:abstractText>Mental disorders are common; they account for the largest global burden of morbidity-more than any other disorder group. A serious challenge to progress in managing mental disorders is that for diagnosis, treatment and early intervention, we rely on late manifestations of disease and patient reports alone with no biological tests. For other complex medical disorders (e.g. coronary heart disease), the identification of early risk processes in the general population during childhood has been critical in terms of informing public health strategies to reduce risks of later disorder. 

In this proposal our starting point is the progress that has been made in gene discoveries from large patient populations that provide independent biologically-based and clinically relevant illness &amp;quot;markers&amp;quot;. We will take these discoveries into the general population and use them to define composite scores of &amp;quot;mental disorder risk allele profiles&amp;quot;. We then identify the impact of these mental disorder genetic risk scores on key aspects of normal child development - &amp;quot;neurodevelopmental&amp;quot; domains (e.g. fear, concentration) to specifically find out which aspects of child development are affected by genetic risk. We will then examine whether gene scores contribute to how these normal childhood processes develop from a very young age to just before puberty (after which time many mental disorders start). We will also begin to examine how tractable the genetic risk score-identified childhood neurodevelopment measures are over time-via one example of an early environmental risk exposure-childhood bullying victimisation.</gtr:abstractText><gtr:technicalSummary>Many mental disorders such as schizophrenia are highly heritable. International studies have led to risk gene and risk gene profile discoveries. However we have yet to understand the processes by which gene variants in the general population become translated into psychiatric disorders. In this proposal, we begin to address this using two UK population cohorts. We focus on childhood as most mental disorders have their origins in childhood so risks begin to operate then. We begin with mental disorder risk allele scores found in large scale gene discovery patient studies and examine their impact in the general population. The hypothesis we will test is that mental disorder risk alleles when summed together as a risk score affect normative and dimensional childhood neurodevelopmental domains in the general population (e.g. mood regulation, attention), that differ from the defining features of illness (e.g. hallucinations) and that will cut across different disorders (as indicated by risk gene profiles). We will examine the impact of mental disorder risk allele scores on the longitudinal course of key neurodevelopmental domains and test, using one example, that they are shifted by exposure to early adversity.</gtr:technicalSummary><gtr:potentialImpactText>1. One impact is to inform scientists as to which neurodevelopmental dimensions are important to assess more deeply in patient and longitudinal high-risk clinical and early intervention studies.

2. A second potential impact is to provide invaluable information on potential early intervention targets for early public health and indicated interventions/preventions-in schools, the community and mental health services. 

3. Finally results will also contribute significantly to on-going ambitions of scientific and clinical communities, as exemplified by NIMH RDoc, to develop cross diagnostic nosology and identify trans-diagnostic dimensional processes relevant to mental disorder. The proposal will have a different impact to other types of research in that it focuses across different mental disorders rather than on one diagnosis.

The time line for these impacts would be 5 to 7 years.

4. The post doc will acquire strong analytic skills by working on two UK cohorts and across research areas-genetics, child psychiatry, adult psychiatry, social epidemiology and across psychiatric disorders. The person appointed will contribute to UK mental health research. We have an excellent track record in developing research capacity at post-doctoral levels and beyond. The timeline for this is 5 years.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>237939</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Psychiatric GWAS Consortium (PGC)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>PGC</gtr:description><gtr:id>FDBD2FBF-B049-4DF3-B378-0DD7A5442D2E</gtr:id><gtr:impact>Research papers as recorded under publications.
PhD studentship data.</gtr:impact><gtr:outcomeId>Xae9avCCcYR-1</gtr:outcomeId><gtr:partnerContribution>PGC involves the largest world wide psychiatric genetics collaboration and data set. This allows us access to the data set for hypothesis generation</gtr:partnerContribution><gtr:piContribution>We contribute to the international Psychiatric Genetics Consortium PGC-data, analysis, initating new papers and helping with co-ordination. AThapar was the ADHD representative for the Cross Disorders Group for 2 years. We remain active contributors to the PGC ADHD group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Mental Health (NIMH)</gtr:department><gtr:description>Collaboration with NIMH</gtr:description><gtr:id>88521E3C-CB46-42CB-A6BD-AFB38349A05A</gtr:id><gtr:impact>Paper submitted for publication</gtr:impact><gtr:outcomeId>58bee343de06f3.03824665-1</gtr:outcomeId><gtr:partnerContribution>We jointly have written a paper on findings to do with the genetic architecture of irritability</gtr:partnerContribution><gtr:piContribution>Joint paper on genetic architecture of irritability.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Psychiatric GWAS Consortium (PGC)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>PGC</gtr:description><gtr:id>315E70E3-B821-4D91-B838-BDF16BBBB887</gtr:id><gtr:impact>Research papers as recorded under publications.
PhD studentship data.</gtr:impact><gtr:outcomeId>Xae9avCCcYR-2</gtr:outcomeId><gtr:partnerContribution>PGC involves the largest world wide psychiatric genetics collaboration and data set. This allows us access to the data set for hypothesis generation</gtr:partnerContribution><gtr:piContribution>We contribute to the international Psychiatric Genetics Consortium PGC-data, analysis, initating new papers and helping with co-ordination. AThapar was the ADHD representative for the Cross Disorders Group for 2 years. We remain active contributors to the PGC ADHD group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Bristol MRC Unit</gtr:description><gtr:id>0A267212-6A0F-4CC9-844E-A868C5ADC862</gtr:id><gtr:impact>Multiple papers and ongoing collaboration</gtr:impact><gtr:outcomeId>56bb88d7b83f96.21625758-1</gtr:outcomeId><gtr:partnerContribution>ALSPAC data and science</gtr:partnerContribution><gtr:piContribution>Joint work on ADHD and risk alleles</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Mental Health (NIMH)</gtr:department><gtr:description>Rutter text book</gtr:description><gtr:id>282BDE3D-A774-41B7-AF6E-F84F91788F02</gtr:id><gtr:impact>The Rutter text book was published in 2015</gtr:impact><gtr:outcomeId>ZiWBDFQMDvt-1</gtr:outcomeId><gtr:partnerContribution>co lead editor of the Rutter text book</gtr:partnerContribution><gtr:piContribution>Lead editor of the Rutter text book</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Giving talk on &quot;ADHD: What next?&quot; at the Royal College of Psychiatrists in Wales Faculty of Child &amp; Adolescent Psychiatry meeting in Wales on 29 April 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6A180467-E67A-40EF-999F-CBCAD24598E4</gtr:id><gtr:impact>Talk to clinical practitioner members of the Royal College of Psychiatrists in Wales Faculty of Child &amp;amp; Adolescent Psychiatry to discuss research into ADHD</gtr:impact><gtr:outcomeId>5731ceae6787f0.16361685</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil on 24.11.2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8FC93196-802C-4317-B749-F738A4FF8D61</gtr:id><gtr:impact>Talk on the subject of ADHD: a developmental journey. A talk given to physicians (neurologists, psychiatrists and other specialities), psychologists, speech therapists and some PhD students from all areas. Followed by a discussion with the audience.</gtr:impact><gtr:outcomeId>5846b3faa74824.59264981</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to the Child Psychiatry Research Society on 6 May 2016 on Neurodevelopmental disorders: what happens when children grow up and why?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>24FF618F-9CB5-4C66-82A5-B79B8441DE0A</gtr:id><gtr:impact>Approximately 30 members of the CPRS attended the meeting where new research activity was presented followed by a discussion. Talks also presented by three other members of the Cardiff University Child and Adolescent Group - Miriam Cooper, Olga Eyre and Rhys Bevan-Jones.</gtr:impact><gtr:outcomeId>5731d09c910ab6.21267051</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Challenge Cardiff Magazine Interview and video</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9948CF9F-6B7F-4815-B5BD-F23D2119F5E9</gtr:id><gtr:impact>To inform and educate</gtr:impact><gtr:outcomeId>56a9ecbf2ca6b1.94928277</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://youtu.be/OSBdjgNDAHE</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Cardiff University Summer School on 12 July 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B65BBA37-037A-4FCC-855C-41F2610FC871</gtr:id><gtr:impact>Talk by Prof Thapar to 60 delegates of the Cardiff University Summer School on Developmental Disorders/Child &amp;amp; Adolescent Psychiatry</gtr:impact><gtr:outcomeId>578632353a7d42.70751036</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff University ADHD Day held on 28.10.2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>34BB9F72-F8DB-4B5F-9AB3-AEE62C123BDD</gtr:id><gtr:impact>Approximately 60 people attended an afternoon of talks and workshops to provide information and support to individuals and families with ADHD.</gtr:impact><gtr:outcomeId>58189cd2d89956.67276803</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ncmh.info/2016/11/07/adhd-open-day-for-families-a-success/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the XIV ProDAH Meeting at the University of Rio Grande Do Sul in Porto Alegre, Brazil on 25.11.2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C574CAD2-2D19-414B-8EE5-2BD17FE6453D</gtr:id><gtr:impact>Talk on ADHD: a developmental journey given to a mix of mater degree, doctoral degree and post-doc students, Professors and clinical instructors of psychiatry and genetics, including students of genetics. 
Joint grant (Wellcome Trust) and joint paper.</gtr:impact><gtr:outcomeId>5846b51cef3930.04240381</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff Univeristy Lab Talk - 26 January 2016 - Attention Deficit Hyperactivity Disorder: a developmental journey</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1A54528E-7A74-4EB7-8CF2-FA79831CB822</gtr:id><gtr:impact>Talk to the Cardiff University MRC Centre staff and students - approximately 70 people attended with discussion time.</gtr:impact><gtr:outcomeId>56d830853185f8.62549676</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at ADHD event organised by Cardiff and Vale Parents' Federation, 24 February 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9797B68E-628C-4572-8189-7612CB003847</gtr:id><gtr:impact>Talk entitled &amp;quot;What do we know about ADHD&amp;quot; given by Sharifah Syed to inform and educate</gtr:impact><gtr:outcomeId>56aa07aaa9a9b5.69481551</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>875937</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Collaborative Award</gtr:description><gtr:end>2020-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>204895/Z/16/ZI</gtr:fundingRef><gtr:id>D27FB926-231B-408B-9C7F-EE63EB5ACE23</gtr:id><gtr:outcomeId>589b0166c86d07.55192206</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Paper in The Lancet entitled &amp;quot;Attention Deficit Hyperactivity Disorder&amp;quot; [In Press] 2016</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>7BA33ED5-A5F1-42A9-9A4D-0F0912754601</gtr:id><gtr:outcomeId>56aa08b737c6c8.45968808</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Welsh Assembly Government and CAMHS Together for Children and Young People Expert Reference Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B9DAF5BE-0ED1-4237-BC00-0C487471BC17</gtr:id><gtr:outcomeId>56aa021980c423.35866819</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F171F9DE-475F-4254-A89B-8356FEA076A1</gtr:id><gtr:title>Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population.</gtr:title><gtr:parentPublicationTitle>Journal of child psychology and psychiatry, and allied disciplines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b00276518bd4961cf04fe7b47dc61cd9"><gtr:id>b00276518bd4961cf04fe7b47dc61cd9</gtr:id><gtr:otherNames>Martin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0021-9630</gtr:issn><gtr:outcomeId>5a995f20343011.53157453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB41CA18-40CF-48C5-89B8-ED627492D0F1</gtr:id><gtr:title>Intellectual Disability and Attention-Deficit/Hyperactivity Disorder: What Does the Clinical and Genetic Overlap Mean for Practice and Research?</gtr:title><gtr:parentPublicationTitle>Journal of the American Academy of Child and Adolescent Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f03f57e6c3ff07d6bcd057de1550e909"><gtr:id>f03f57e6c3ff07d6bcd057de1550e909</gtr:id><gtr:otherNames>Thapar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0890-8567</gtr:issn><gtr:outcomeId>589afba82d9647.85791381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCBCFC72-B6A5-44C2-9180-2E42B377E652</gtr:id><gtr:title>Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5f9002ebab783a1944df0f5d58b718"><gtr:id>6a5f9002ebab783a1944df0f5d58b718</gtr:id><gtr:otherNames>Riglin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>589afba7d63846.72780374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D31A583-836A-412B-ABB8-0203F07C7CA7</gtr:id><gtr:title>Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development.</gtr:title><gtr:parentPublicationTitle>Molecular autism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90ee33f608de0da32ce499f2d9f707f0"><gtr:id>90ee33f608de0da32ce499f2d9f707f0</gtr:id><gtr:otherNames>Stergiakouli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5926cd27043141.20573109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>591ED5E1-5D29-4A5B-96BE-B8B295A35D08</gtr:id><gtr:title>Schizophrenia polygenic risk score and psychotic risk detection-Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5f9002ebab783a1944df0f5d58b718"><gtr:id>6a5f9002ebab783a1944df0f5d58b718</gtr:id><gtr:otherNames>Riglin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5926cd277e5574.61508923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FBA08D3-5F69-4C6D-AB6A-D85DCF865786</gtr:id><gtr:title>Schizophrenia polygenic risk score and psychotic risk detection-Authors' reply.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5f9002ebab783a1944df0f5d58b718"><gtr:id>6a5f9002ebab783a1944df0f5d58b718</gtr:id><gtr:otherNames>Riglin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>59b68125810261.86536021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDACA361-C858-48CF-9439-67C16015BB10</gtr:id><gtr:title>The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5f9002ebab783a1944df0f5d58b718"><gtr:id>6a5f9002ebab783a1944df0f5d58b718</gtr:id><gtr:otherNames>Riglin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>5a37b7c0179231.11489869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6A56F77-46A9-4FC9-81A6-74F7CFA57CF8</gtr:id><gtr:title>Neurodevelopmental disorders.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f03f57e6c3ff07d6bcd057de1550e909"><gtr:id>f03f57e6c3ff07d6bcd057de1550e909</gtr:id><gtr:otherNames>Thapar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>589afba7b5e286.17520792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96362F1C-C83C-416D-A8BC-F75948202391</gtr:id><gtr:title>Association between polygenic risk scores for attention-deficit hyperactivity disorder and educational and cognitive outcomes in the general population.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90ee33f608de0da32ce499f2d9f707f0"><gtr:id>90ee33f608de0da32ce499f2d9f707f0</gtr:id><gtr:otherNames>Stergiakouli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>582b0793358647.84665324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1581ED40-F3A6-48EF-81DF-8D97EBC968BF</gtr:id><gtr:title>Investigating the genetic underpinnings of early-life irritability.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5f9002ebab783a1944df0f5d58b718"><gtr:id>6a5f9002ebab783a1944df0f5d58b718</gtr:id><gtr:otherNames>Riglin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>5a1eb502957cf0.96784621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>654E70EE-69D6-452F-92BB-466479073753</gtr:id><gtr:title>Life Span Studies of ADHD-Conceptual Challenges and Predictors of Persistence and Outcome.</gtr:title><gtr:parentPublicationTitle>Current psychiatry reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/313a929940dca476a9ec80d71158e168"><gtr:id>313a929940dca476a9ec80d71158e168</gtr:id><gtr:otherNames>Caye A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1523-3812</gtr:issn><gtr:outcomeId>582b0791823476.80933451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B047011F-C464-4EA8-80D6-3DF6FB4D9FCE</gtr:id><gtr:title>Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.</gtr:title><gtr:parentPublicationTitle>JAMA psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5f9002ebab783a1944df0f5d58b718"><gtr:id>6a5f9002ebab783a1944df0f5d58b718</gtr:id><gtr:otherNames>Riglin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-622X</gtr:issn><gtr:outcomeId>582b0848754b37.93782521</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M012964/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>